Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

卷 52, 期 3, 页码 408-417

OXFORD UNIV PRESS INC

Transcatheter aortic valve implantation; Surgical aortic valve replacement; Durability; Long-term outcomes; Structural valve deterioration; Bioprosthetic valve failure; Bioprosthetic valve dysfunction

Cardiac & Cardiovascular Systems Respiratory System Surgery

1. Abbott Vascular
2. AstraZeneca
3. Bayer
4. Pfizer
5. Daiichi Sankyo
6. Direct Flow Medical
7. Medtronic
8. Boston Scientific
9. Edwards Lifesciences
10. Valtech
11. General Electric
12. St. Jude Medical
13. Servier
14. Symetis
15. Bayer Schering Pharma
16. Biosensors
17. Microport
18. Highlife
19. Terumo Inc.
20. Bristol-Myers Squibb
21. B. Braun Melsungen
22. Biotronik
23. HeartFlow
24. The Medicines Company
25. Sanofi Aventis
26. Actelion
27. Guerbet
28. Johnson Johnson
29. Merck Sharp Dohme
30. Novartis
31. Sorin Group
32. Eli-Lilly
33. Volcano
34. Cardiac Dimensions